Diurnal and Nocturnal Effect of Travatan With SofZia Preservative on Intraocular Pressure and Ocular Perfusion Pressure
Sponsored by University of Colorado, Denver
About this trial
Last updated 10 years ago
Study ID
Status
Type
Placebo
Accepting
Trial Timing
Ended 13 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* Diagnosis of open-angle glaucoma or ocular hypertension, including pigment dispersion glaucoma and pseudoexfoliation glaucoma
* Age ≥ 18 or ≤ 90 years, of either gender, or any race/ethnicity
Exclusion Criteria
* Females who are currently pregnant or planning to become pregnant, as determined by history during the study period
* Diagnosis of any other form of glaucoma other than open-angle
* Schaffer angle grade < 2 in either eye by gonioscopy
* Chronic, recurrent, or severe inflammatory eye disease
* Intraocular surgery within 6 months or laser within 3 months
* History of active, recurrent, or chronic ocular infection with the Herpes Simplex Virus
* History of cystoid macular edema
* Inability to safely discontinue all ocular medications for 4 weeks
* Patients who smoke or have irregular daily sleep patterns
* Patients who have started or changed glucocorticoids therapy in the last 3 months
* Patients who are currently undergoing medical marijuana therapy
* Any use of a non-FDA approved medication for glaucoma in the last 3 months
